Objectionable Name. To the extent ​ desires to change the name and/or logo set forth on the ​’s Signage, such name and/or logo shall not have a name which relates to an entity which is of a character or reputation, or is associated with a political faction or orientation, which is inconsistent with the quality of the Project, or which would otherwise reasonably offend a ​ of Comparable Buildings (an “Objectionable Name”). The parties hereby agree that the name “Penumbra, Inc.” or any reasonable derivation thereof, shall not be deemed an Objectionable Name.

Name Change. Immediately following the Closing, ​ shall file amendments to ​’s Articles of Organization with the Michigan Secretary of State and any other corporate registry recording its qualification or license to do business changing its corporate name to a name or names that Purchaser reasonably determines is not likely to cause confusion with ​’s current name or any other name included in the Assets. ​ further agree that, following the Closing, neither ​ nor any of its Affiliates will adopt any name which Purchaser reasonably determines is likely to cause confusion with ​’s current name for any business and will not otherwise infringe upon the names, or holding themselves out as the successors to the Business.

Name Change. References to “Repro Med Systems, Inc. d/b/a ​” throughout the Employment Agreement and Option Agreement are hereby deleted and replaced with “​”

(Print Name of Joint Investor)

Agreement, Shares and Warrant. The Company shall have duly executed and delivered to the Investor this Agreement. At the Closing, the Company shall have # issued or caused to be issued to the Investor one or more certificates representing the Shares purchased by the Investor hereby, registered in the name of the Investor or its designee, and # duly executed and delivered to the Investor the Warrant purchased by the Investor hereby, registered in the name of the Investor or its designee.

“Related Alternate Investor” means, with respect to any Conduit Investor, each Alternate Investor set forth opposite such Conduit Investor’s name on [Schedule A] (and any transferee of any such Alternate Investor pursuant to [Section 11.8]).

Investor Representations. This Note has been issued subject to certain investment representations of the original Holder set forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal and state securities laws and regulations.

Investor Shares. During the Voting Period (as defined below), the Investors agree to vote all shares of voting capital stock of the Company registered in the Investors’ names or beneficially owned by the Investors (as determined by Rule 13d-3 of the Exchange Act), including any and all voting securities of the Company legally or beneficially acquired by the Investors after the date hereof (hereinafter collectively referred to as the “Investor Shares”), in accordance with the provisions of this [Section 2]. For purposes of this Agreement, the “Voting Period” shall mean the period of time beginning on the date of this Agreement and ending on the earliest to occur of # following the New Director’s appointment to the Board, the date that the Company notifies the Investors in writing (the “Required Notice”) that it does not intend to re-nominate the New Director as a director of the Company at any annual meeting at which the New Director would be up for re-election based on his term of appointment (such notice to be provided not later than the date that is 10 calendar days prior to the deadline established pursuant to the Company’s Amended and Restated Bylaws for the submission of stockholder nominations for the applicable annual meeting where such nomination is not to be included in the Company’s proxy statement for such annual meeting), # the date that is fifteen (15) business days prior to the deadline for the submission of stockholder nominations for the Company’s 2021 Annual Stockholder Meeting (but only in the event that the New Director has tendered his resignation on or before such date), or # the date of the Company’s 2021 Annual Stockholder Meeting.

Accredited Investor. Employee understands that the Company’s obligations under this Agreement have not been registered under the Securities Exchange Act of 1933, as amended (the “Securities Act”), or any state securities laws. Employee is an “accredited investor” as defined in Regulation D under the Securities Act, and has such knowledge and experience in financial and business matters that he is able to evaluate the risks and benefits of this Agreement. There has been direct communication and negotiation between the Company and Employee with respect to this Agreement. The Company has made available to Employee information regarding the business of the Company and the risks inherent therein, and Employee has had the opportunity to ask questions of, and receive responses from, the Company regarding such matters and the terms and conditions of this Agreement.

Accredited Investor. Such Investor is an "accredited investor" within the meaning of Rule 501 of Regulation D promulgated under the Securities Act, as presently in effect.